Mark Egly Foundation
  • Why We Exist
    Our Mission
    Our PromiseOur ImpactOur AgendaMark's StoryMark's PatentCurrent Partnerships
    Standard of Care
    What is the SOCChanging the SOCOur Research StrategyKey InitiativesNews
    Alpha1 Antitrypsin
    State of the FieldOur Research StrategyKey Research InitiativesResearch News
  • Understanding Alpha1
    About Alpha1
    What is Alpha1What is Alpha1 Antitrypsin DeficiencySymptomsMedication & TreatmentsRelated ConditionsAge Relevance to Diagnosis
    Alpha1 Journey
    Newly Diagnose ResourcesAlpha1 360Building a Support TeamWork & Financial ConcernsRelationshipsMental & Physical Health
    Education & Inspiration
    Alpha1 and You EventsAsk the MDWebinarsPodcastsBooks & ResourcesAlpha1 Friend Network
  • For Researchers
    Apply for Grants
    What We FundFunding OpportunitiesWorking with UsFunded Studies
  • Take Action
    Donate
    Donate NowMonthly Giving ProgramWays to GiveIn TributeEmployee GivingPlanned Giving
    Advocate
    Contact Your PolicymakersOur Public Policy PrioritiesAdvocacy ResourcesPolicy Updates

What is Alpha1 Antitrypsin Deficiency

Alpha1 Antitrypsin provides antiprotease protective screens throughout the entire body, not just the lungs!

Alpha1 Antitrypsin Deficiency can be many things, and defining it can be tricky because of so many variations in defining precisely what it is. Many define Alpha1 Antitrypsin as having specific alleles. Therefore, Alpha1 Antitrypsin Deficiency is a condition that is extremely poorly defined and can lead to misconceptions.

Mark Egly has done extensive research on the condition. Mark is a person who has Alpha1 Antitrypsin Deficiency. The world recognizes the disease as rare, and Mark would instead teach that Alpha1 Antitrypsin Deficiency is a rarely diagnosed disease. Under current definitions, identification, and potential subsequent treatment of AATD needs an additional standard of care to be implemented. Our Foundation is moving forward with new definitions that are less restrictive with respect to patient awareness and care!

What can be defined about Alpha1 Antitrypsin Deficiency is:

  • It is a genetic disorder involving the SERPINA1 gene
  • A genetic situation where the SERPINA1 gene do not allow the body to make enough Alpha1 Antitrypsin to protect the body adequately from excess neutrophils and/or
  • It is a genetic situation in which the person has improperly unfolded Alpha1 Antitrypsin from the liver. This improper unfolding causes potential liver damage and lowers the amount of Alpha1 Antitrypsin capable of protecting the body and its tissue to the best of its ability.

Alpha1 Antitrypsin Deficiency can be described by allele variations, with the M allele typically considered the best allele for high levels of protection. Here is a list of almost all the known alleles at the time of Mark's patent submission.

Known Alleles of the SERPINA1 Gene

AllelePathogenic MutationConsequence (SIFT and Polyphen scores)
Q0Faroc.-5+ 2dupTAATD: protein absence
Ip.Arg39CysAATD: protein deficiency (0.03; 0.591)
MMaltonp.Phe52delAATD: protein deficiency (0; 0.99)
MPalermop.Phe52delAATD: protein deficiency (0; 0.99)
Q0Lisbonp.Thr68IleAATD: Protein absence (0; 0.98)
PGaiap.Glu162GlyAATD: protein deficiency (0.01; 0.80)
PLowellp.Asp256ValAATD: protein deficiency (0; 0.97)
Q0Gaiap.Leu263ProAATD: protein absence (0; 0.972)
Tp.Glu264ValAATD: protein deficiency (0; 0.93)
Q0Oliveira do Dourop.Arg281Lysfs*17AATD: protein absence
Q0Ourémp.Leu353Phefs*24AATD: protein absence
MHerleenp.Pro369LeuAATD: protein deficiency (0; 0.99)
MWurzburgp. Pro369SerAATD: protein deficiency (0; 0.99)
Q0Vila Realp.Met374Leufs*19AATD: protein absence
-p.Pro-23LeuPossibly damaging (0.03; 0.50)
ZWrexhamp.Ser-19LeuNot linked to AATD (0.05; 0.50)
-p.Trp-18CysProbably damaging (0.01; 0.91)
-p.Leu-13MetProbably damaging (0; 0.99)
VMunichp.Asp2AlaNot linked to AATD (0.06; 0.02)
-p.Pro3LeuBenign (0.55; 0)
-p.His15AsnBenign (0.41; 0)
-p.His16ArgBenign (0.13; 0)
-p.Ala34SerPossibly damaging (0.06; 0.61)
M5Karlsruhep.Ala34ThrNot linked to AATD (0.13; 0.277)
Q0Knowloonp.Tyr38TerAATD: protein absence
MProcidap.Leu41ProAATD: protein deficiency (0.19; 0.99)
MVarallop.Leu41-Phe51delfs*20AATD: protein deficiency
-p.His43GlnBenign (0.35; 0.011)
M6Bonnp.Ser45PheNot linked to AATD (0; 0.867)
-p.Ser47ArgNot linked to AATD (0.05; 0.01)
MNichinanp.Phe52delAATD: protein deficiency (0; 0.99)
Siiyamap.Ser53PheAATD: protein deficiency (0; 1)
M6Passaup.Ala60ThrNot linked to AATD (0; 0.668)
-p.Leu66ArgProbably damaging (002; 0.99)
MMineral Springsp.Gly67GluAATD: protein deficiency (0:0.99)
-p.Thr72AlaPossibly damaging (0; 0.82)
-p.Leu84ArgBenign (0.02; 0.10)
ZBristolp.Thr85MetAATD: protein deficiency (0.02; 0.94)
Q0Ludwisghafenp.Ile92AsnAATD: protein absence (0; 0.96)
Q0Soestp.Thr102Profs*10AATD: protein absence
Q0Devonp.Gly115SerAATD: protein deficiency (0.1; 0.97)
Q0Newportp.Gly115SerAATD: protein deficiency (0.1; 0.97)
ZNewportp.Gly115SerAATD: protein deficiency (0.1; 0.97)
-p.Leu120PhePossibly damaging (0; 0.87)
-p.Glu122LysBenign (0.15; 0.27)
-p.Lys129GluProbably damaging (0.07; 0.91)
-p.Phe130LeuProbably damaging (0; 0.99)
-p.Ala142AspProbably damaging (0; 0.98)
Vp.Gly148ArgNot linked to AATD (1; 0)
M2Obernburgp.Gly148TrpNot linked to AATD (0.01; 0.70)
-p.Glu151LysBenign (0.27; 0.14)
Queen'sp.Lys154AsnAATD: protein deficiency (0.06; 0.844)
Q0Chillichotep.Gln156TerAATD: protein absence
Q0Granite Fallsp.Tyr160TerAATD: protein absence
Q0Bredevoortp.Tyr160TerAATD: protein absence
Q0amersfoortp.Tyr160TerAATD: protein absence
-p.Val161MetProbably damaging (0; 0.99)
-p.Leu172SerProbably damaging (0; 0.99)
Q0Corkp.Thr180Serfs*11AATD: protein absence
-p.Lys193TerAATD: protein absence
Q0Trasteverep.Trp194TerAATD: protein absence
-p.Pro197HisProbably damaging (0; 0.98)
-p.Asp207GluBenign (0.09; 0.01)
-p.Val210MetPossibly damaging (0; 0.86)
-p.Val216MetProbably damaging (0; 0.99)
Q0Bellinghamp.Lys217TerAATD: protein absence
Fp.Arg223CysAltered function (0.02; 0.52)
-p.Arg223HisBenign (0.09; 0.33)
PbresciaGly225ArgAATD: protein deficiency (0.01; 0.95)
-p.Gly225AlaProbably damaging (0; 0.97)
-p.Lys233AsnBenign (0.14; 0)
Q0Perugiap.Val239Cysfs*3AATD: protein absence
PDuartep.Asp256ValAATD: protein deficiency (0; 0.97)
-p.Gly258ArgProbably damaging (0; 0.99)
Q0Bresciap.Glu257TerAATD: protein absence
MPisap.Lys259ArgAATD: protein deficiency (0; 0.958)
Q0Cairop.Lys259TerAATD: protein absence
Q0Milanop.Lys259-Glu264delTerAATD: protein absence
-p.His262TyrBenign (0.11; 0.06)
-p.His269GlnBenign (0.31; 0.00)
-p.Leu276ProProbably damaging (0.03; 0.92)
-p.Asn278IleBenign (0.31; 0.00)
IEuskadip.Arg281delNot linked to AATD
-p.Ala284SerBenign (0.02; 0.15)
-p.Ile293Hisfs*6AATD: protein absence
Q0Torinop.Try297TerAATD: protein absence
-p.Asp298GluBenign (0.05; 0.08)
-p.Val302IleNot linked to AATD (1; 0.04)
Q0Cosenzap.Gln305TerAATD: protein absence
-p.Gly307SerProbably damaging (0; 0.97)
-p.Val311IleBenign (0.29; 0.07)
-p.Gly315GluBenign (1; 0.01)
Q0Hong Kongp.Leu318Serfs*17AATD: protein absence
Q0New Hopep.Gly320GluAATD: Protein absence (0; 0.98)
-p.Gly320ArgProbably damaging (0.02; 0.99)
-p.Ala325ProBenign (0.26; 0.01)
Q0Pordenonep.Leu327Argfs*12AATD: protein absence
SMunichp.Ser330PheNot linked to AATD (0; 0.89)
-p.Val333MetPossibly damaging (0.08:0.53)
King'sp.His334AspAATD: protein deficiency (0.02; 0.943)
-p.Lys335GluPossibly damaging (0; 0.56)
WBethesdap.Ala336ThrAATD: protein deficiency (60%) (0; 0.93)
-p.Val337GlyProbably damaging (0; 0.99)
-p.Val337Valfs*2AATD: protein absence
-p.Asp341GluPossibly damaging (0.03; 0.66)
Pdonauworthp.Asp341AsnNot linked to AATD (0.06; 0.44)
PSaint albansp.Asp341AsnNot linked to AATD (0.06; 0.44)
ZAugsburgp.Glu342LysAATD: protein deficiency (0.07; 0.99)
-p.Gly344GluProbably damaging (0.08; 0.99)
Q0Mattawap.Leu353Phefs*24AATD: protein absence
MPittsburghp.Met358ArgAltered function (0.24; 0.00)
-p.Met358IleLikely Altered function (0.25; 0.00)
LOffenbachp.Pro362ThrNot linked to AATD (0; 0.10)
São Tomép.Pro362HisNot linked to AATD (0.04; 0.289)
Q0Boltonp.Pro362Argfs*12AATD: protein absence
Q0Claytonp.Pro362Profs*15AATD: protein absence
Q0Saarbrueckenp.Pro362Profs*15AATD: protein absence
XChristchurchp.Glu363LysNot linked to AATD (0.74; 0.192)
ETaurisamop.Lys368GluAATD: protein deficiency (0.01:0.083)
Q0Dublinp.Phe370Leufs*4AATD: protein absence
-p.Ile375ValBenign (0.4; 0.00)
-p.Met385ValBenign (1; 0.01)
YBarcelonap.Pro391HisAATD: protein deficiency (0; 1)
Yorzinuovip.Pro391HisAATD: protein deficiency (0; 1)
Q0Isola di ProcidaDel 17 Kb including exons II-VAATD: protein absence
Q0RiedenburgSERPINA1 deletionAATD: protein absence
Q0Savannahg.5307_5308ins8bpAATD: protein absence
Q0Portoc.-5 + 1G > AAATD: protein absence
Q0Madridc.-5+ 2dupT-
Q0Bonny bluec.-4+1GdelAATD: protein absence
Q0Westc.-4+1G>TAATD: protein absence